Infection Control Market Size, Share, Growth, and Industry Analysis

The Infection Control Market plays a critical role in supporting healthcare safety by providing products and services designed to prevent contamination and the transmission of infectious pathogens. Hospitals, clinics, pharmaceutical facilities, research laboratories, and other healthcare environments rely on sterilization, disinfection, protective barriers, and infection-control supplies to maintain safe operating conditions.

Market Research Future estimates that the global infection control market reached USD 109.50 billion in 2025 and is expected to grow to USD 213.38 billion by 2035, expanding at a CAGR of 6.90% during the 2026–2035 forecast period. This expansion reflects the growing importance of infection prevention across healthcare systems.

Healthcare-associated infections remain a significant concern, encouraging hospitals to strengthen infection-prevention protocols. Healthcare facilities are investing in sterilization equipment, disinfectants, protective equipment, environmental monitoring, and hand-hygiene solutions. The continued expansion of surgical procedures further increases demand because sterile environments and appropriately processed medical instruments are essential for many interventions.

The market is also benefiting from improvements in sterilization technology. Traditional methods are increasingly complemented by advanced low-temperature technologies, including hydrogen peroxide-based systems. These solutions are particularly useful for instruments and equipment that may be damaged by conventional high-temperature processing.

Sterilization products and services accounted for approximately 39.10% of the market in 2025, highlighting the importance of sterilization within the broader infection-control ecosystem. Meanwhile, protective barriers are expected to grow at approximately 7.15% CAGR through 2035 as healthcare providers increasingly adopt single-use protective products.

Hospitals and clinics remain the largest end-user category, representing around 35.15% of the market in 2025. These facilities require continuous supplies of infection-control products because of their large patient populations, surgical activities, intensive-care services, and diagnostic procedures.

North America held approximately 36.20% of the global market in 2025. Asia-Pacific, however, is expected to demonstrate faster growth, supported by hospital construction, healthcare modernization, and improving access to medical services.

The future of infection control will increasingly combine physical products with digital monitoring, automation, and predictive analytics. These developments can improve infection surveillance, operational efficiency, and compliance, creating new growth opportunities for market participants.